Concepedia

Natsumi Ogawa

NO

3

Publications

63

Citations

3

H-Index

2019

Active since

Affiliations

Tokai University(Current)

Nippon Shinyaku (Japan)

Tokyo University of Science

Juntendo University

Natsumi Ogawa is an author at Tokai University specializing in immunology, medicine, and signal transduction.

Top concepts

MedicineImmunologyCell BiologyInflammationPharmacologyMolecular SignalingSignal TransductionChronic InflammationInflammatory DiseaseOncology

Publications per year

2019–2020

3

Publications

3

Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses

Kenya Tamada, Shingo Nakajima, Natsumi Ogawa et al. · Biochemical and Biophysical Research Communications · 2019 · 32 citations

Inflammation, Cytokine, Anti-inflammatory +12

Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Koji Izutsu, Kazuhito Yamamoto, Koji Kato et al. · International Journal of Hematology · 2020 · 20 citations

Phase 1/2, Lymphoid Neoplasia, Hematological Malignancy +9

Trimebutine attenuates high mobility group box 1–receptor for advanced glycation end-products inflammatory signaling pathways

Shingo Nakajima, Natsumi Ogawa, Natsuki Yokoue et al. · Biochemical and Biophysical Research Communications · 2020 · 11 citations

Inflammation, Molecular Pharmacology, Anti-inflammatory +11

Rows per page

1–3 of 3